644-P: Racial Ethnic Disparities in Prescription of GLP-1 Receptor Agonists for People at High Risk for Diabetes on Atypical Antipsychotics

Introduction: Atypical antipsychotics (AAP) significantly increase the risk of obesity and type 2 diabetes (T2D). GLP-1 receptor agonists (GLP-1 RA) are weight-loss medications which may be beneficial in treating AAP-induced weight gain. We evaluated trends in prescriptions of GLP-1 RA among patient...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Diabetes (New York, N.Y.) N.Y.), 2024-06, Vol.73 (Supplement_1), p.1
Hauptverfasser:	SAM VARGHESE, JITHIN, GOLDSMITH, DAVID, WAFORD, RACHEL, CHAKKALAKAL, ROSETTE, ALI, MOHAMMED K., PASQUEL, FRANCISCO J., COTES, ROBERT O.
Format:	Artikel
Sprache:	eng
Schlagworte:	Agonists Antipsychotics Comorbidity Cultural differences Diabetes Diabetes mellitus (non-insulin dependent) Ethnicity GLP-1 receptor agonists Hypercholesterolemia Minority & ethnic groups Obesity Prescriptions Psychotropic drugs Race Trends Weight Weight control
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!